Cullen Capital Management, LLC Novartis Ag Transaction History
Cullen Capital Management, LLC
- $8.47 Billion
- Q1 2025
A detailed history of Cullen Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cullen Capital Management, LLC holds 2,108,684 shares of NVS stock, worth $238 Million. This represents 2.77% of its overall portfolio holdings.
Number of Shares
2,108,684
Previous 2,156,619
2.22%
Holding current value
$238 Million
Previous $210 Million
12.02%
% of portfolio
2.77%
Previous 2.48%
Shares
33 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.33 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.17 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$970 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$796 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$763 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $243B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...